Global Prostate Health Market Size, Share, and COVID-19 Impact Analysis, By Disease Indication (Benign Prostate Hyperplasia (BPH), Prostate Cancer, Alpha Blockers, Prostatitis, and Others), By Treatment (Radiation Therapy, Hormone ADT, AR Directed Therapies, Cytotoxic Agents, and Therapeutics), By Distribution Channel (E-Commerce Stores, Pharmacies, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Industry: Healthcare
RELEASE DATE Jun 2024
REPORT ID SI4514
PAGES 240
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Disease Indication
      2. Market Attractiveness Analysis By Treatment
      3. Market Attractiveness Analysis By Distribution Channel
      4. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. The incidence of benign prostatic hyperplasia is rising
    3. Restraints
      1. Adverse reactions linked to BPH drugs.
    4. Opportunities
      1.  Promising pipelines of products.
    5. Challenges

5.5.1.   Men’s insufficient knowledge about prostate health.

  1. Global Prostate Health Market Analysis and Projection, By Disease Indication
    1. Segment Overview
    2. Benign Prostate Hyperplasia (BPH)
    3. Prostate Cancer
    4. Alpha Blockers
    5. Prostatitis
    6. Others
  2. Global Prostate Health Market Analysis and Projection, By Treatment
    1. Segment Overview
    2. Radiation Therapy
    3. Hormone ADT
    4. AR Directed Therapies
    5. Cytotoxic Agents and Therapeutics
    6. Others
  3. Global Prostate Health Market Analysis and Projection, By Distribution Channel
    1. Segment Overview
    2. E-Commerce Stores
    3. Pharmacies
    4. Others
  4. Global Prostate Health Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  5. Global Prostate Health Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Prostate Health Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  6. Company Profiles
    1. AbbVie, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2. Pfizer, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3. Bayer AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.    Lily
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5. Ferring Pharmaceuticals Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Nucleai, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7. Clovis Oncology, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Eli Lilly and Company
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Astellas Pharma Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Johnson & Johnson
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11. Abbott Laboratories
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12. Gilead Sciences, Inc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13. Teva Pharmaceutical Industries Ltd
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Amgen, Inc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Prostate Health Market, By Disease Indication, 2023-2033(USD Billion)
  2. Global Benign Prostate Hyperplasia (BPH), Prostate Health Market, By Region, 2023-2033(USD Billion)
  3. Global Prostate Cancer, Prostate Health Market, By Region, 2023-2033(USD Billion)
  4. Global Alpha Blockers, Prostate Health Market, By Region, 2023-2033(USD Billion)
  5. Global Prostatitis, Prostate Health Market, By Region, 2023-2033(USD Billion)
  6. Global Others, Prostate Health Market, By Region, 2023-2033(USD Billion)
  7. Global Prostate Health Market, By Treatment, 2023-2033(USD Billion)
  8. Global Radiation Therapy, Prostate Health Market, By Region, 2023-2033(USD Billion)
  9. Global Hormone ADT, Prostate Health Market, By Region, 2023-2033(USD Billion)
  10. Global AR Directed Therapies, Prostate Health Market, By Region, 2023-2033(USD Billion)
  11. Global Cytotoxic Agents and Therapeutics, Prostate Health Market, By Region, 2023-2033(USD Billion)
  12. Global Others, Prostate Health Market, By Region, 2023-2033(USD Billion)
  13. Global Prostate Health Market, By Distribution Channel, 2023-2033(USD Billion)
  14. Global E-Commerce Stores, Prostate Health Market, By Region, 2023-2033(USD Billion)
  15. Global Pharmacies, Prostate Health Market, By Region, 2023-2033(USD Billion)
  16. Global Others, Prostate Health Market, By Region, 2023-2033(USD Billion)
  17. North America Prostate Health Market, By Disease Indication, 2023-2033(USD Billion)
  18. North America Prostate Health Market, By Treatment, 2023-2033(USD Billion)
  19. North America Prostate Health Market, By Distribution Channel, 2023-2033(USD Billion)
  20. U.S.  Prostate Health Market, By Disease Indication, 2023-2033(USD Billion)
  21. U.S.  Prostate Health Market, By Treatment, 2023-2033(USD Billion)
  22. U.S.  Prostate Health Market, By Distribution Channel, 2023-2033(USD Billion)
  23. Canada Prostate Health Market, By Disease Indication, 2023-2033(USD Billion)
  24. Canada Prostate Health Market, By Treatment, 2023-2033(USD Billion)
  25. Canada Prostate Health Market, By Distribution Channel, 2023-2033(USD Billion)
  26. Mexico Prostate Health Market, By Disease Indication, 2023-2033(USD Billion)
  27. Mexico Prostate Health Market, By Treatment, 2023-2033(USD Billion)
  28. Mexico Prostate Health Market, By Distribution Channel, 2023-2033(USD Billion)
  29. Europe Prostate Health Market, By Disease Indication, 2023-2033(USD Billion)
  30. Europe Prostate Health Market, By Treatment, 2023-2033(USD Billion)
  31. Europe Prostate Health Market, By Distribution Channel, 2023-2033(USD Billion)
  32. Germany Prostate Health Market, By Disease Indication, 2023-2033(USD Billion)
  33. Germany Prostate Health Market, By Treatment, 2023-2033(USD Billion)
  34. Germany Prostate Health Market, By Distribution Channel, 2023-2033(USD Billion)
  35. France Prostate Health Market, By Disease Indication, 2023-2033(USD Billion)
  36. France Prostate Health Market, By Treatment, 2023-2033(USD Billion)
  37. France Prostate Health Market, By Distribution Channel, 2023-2033(USD Billion)
  38. U.K.  Prostate Health Market, By Disease Indication, 2023-2033(USD Billion)
  39. U.K.  Prostate Health Market, By Treatment, 2023-2033(USD Billion)
  40. U.K.  Prostate Health Market, By Distribution Channel, 2023-2033(USD Billion)
  41. Italy Prostate Health Market, By Disease Indication, 2023-2033(USD Billion)
  42. Italy Prostate Health Market, By Treatment, 2023-2033(USD Billion)
  43. Italy Prostate Health Market, By Distribution Channel, 2023-2033(USD Billion)
  44. Spain Prostate Health Market, By Disease Indication, 2023-2033(USD Billion)
  45. Spain Prostate Health Market, By Treatment, 2023-2033(USD Billion)
  46. Spain Prostate Health Market, By Distribution Channel, 2023-2033(USD Billion)
  47. Asia Pacific Prostate Health Market, By Disease Indication, 2023-2033(USD Billion)
  48. Asia Pacific Prostate Health Market, By Treatment, 2023-2033(USD Billion)
  49. Asia Pacific Prostate Health Market, By Distribution Channel, 2023-2033(USD Billion)
  50. Japan Prostate Health Market, By Disease Indication, 2023-2033(USD Billion)
  51. Japan Prostate Health Market, By Treatment, 2023-2033(USD Billion)
  52. Japan Prostate Health Market, By Distribution Channel, 2023-2033(USD Billion)
  53. China Prostate Health Market, By Disease Indication, 2023-2033(USD Billion)
  54. China Prostate Health Market, By Treatment, 2023-2033(USD Billion)
  55. China Prostate Health Market, By Distribution Channel, 2023-2033(USD Billion)
  56. India Prostate Health Market, By Disease Indication, 2023-2033(USD Billion)
  57. India Prostate Health Market, By Treatment, 2023-2033(USD Billion)
  58. India Prostate Health Market, By Distribution Channel, 2023-2033(USD Billion)
  59. South America Prostate Health Market, By Disease Indication, 2023-2033(USD Billion)
  60. South America Prostate Health Market, By Treatment, 2023-2033(USD Billion)
  61. South America Prostate Health Market, By Distribution Channel, 2023-2033(USD Billion)
  62. Brazil Prostate Health Market, By Disease Indication, 2023-2033(USD Billion)
  63. Brazil Prostate Health Market, By Treatment, 2023-2033(USD Billion)
  64. Brazil Prostate Health Market, By Distribution Channel, 2023-2033(USD Billion)
  65. The Middle East and Africa Prostate Health Market, By Disease Indication, 2023-2033(USD   Billion)
  66. The Middle East and Africa Prostate Health Market, By Treatment, 2023-2033(USD   Billion)
  67. The Middle East and Africa Prostate Health Market, By Distribution Channel, 2023-2033(USD Billion)
  68. UAE Prostate Health Market, By Disease Indication, 2023-2033(USD Billion)
  69. UAE Prostate Health Market, By Treatment, 2023-2033(USD Billion)
  70. UAE Prostate Health Market, By Distribution Channel, 2023-2033(USD Billion)
  71. South Africa Prostate Health Market, By Disease Indication, 2023-2033(USD Billion)
  72. South Africa Prostate Health Market, By Treatment, 2023-2033(USD Billion)
  73. South Africa Prostate Health Market, By Distribution Channel, 2023-2033(USD Billion)

 

List of Figures 

  1. Global Prostate Health Market Segmentation
  2. Prostate Health Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Prostate Health Market
  9. Top Winning Strategies, 2023-2033
  10. Top Winning Strategies, By Development, 2023-2033(%)
  11. Top Winning Strategies, By Company, 2023-2033
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2023
  18. Market Share Analysis, 2023
  19. Restraint and Drivers:  Prostate Health Market
  20. Prostate Health Market Segmentation, By Disease Indication
  21. Prostate Health Market For Benign Prostate Hyperplasia (BPH), By Region, 2023-2033 ($ Billion)
  22.  Prostate Health Market For Prostate Cancer, By Region, 2023-2033 ($ Billion)
  23. Prostate Health Market For Alpha Blockers, By Region, 2023-2033 ($ Billion)
  24. Prostate Health Market For Prostatitis, By Region, 2023-2033 ($ Billion)
  25. Prostate Health Market For Others, By Region, 2023-2033 ($ Billion)
  26.  Prostate Health Market Segmentation, By Treatment
  27.  Prostate Health Market For Radiation Therapy, By Region, 2023-2033 ($ Billion)
  28.  Prostate Health Market For Hormone ADT, By Region, 2023-2033 ($ Billion)
  29. Prostate Health Market For AR Directed Therapies, By Region, 2023-2033 ($ Billion)
  30. Prostate Health Market For Cytotoxic Agents and Therapeutics, By Region, 2023-2033 ($ Billion)
  31. Prostate Health Market For Others, By Region, 2023-2033 ($ Billion)
  32. Prostate Health Market Segmentation, By Distribution Channel
  33. Prostate Health Market For E-Commerce Stores, By Region, 2023-2033 ($ Billion)
  34. Prostate Health Market For Pharmacies, By Region, 2023-2033 ($ Billion)
  35. Prostate Health Market For Others, By Region, 2023-2033 ($ Billion)
  36. AbbVie, Inc.: Net Sales, 2023-2033 ($ Billion)
  37. AbbVie, Inc.: Revenue Share, By Segment, 2023 (%)
  38. AbbVie, Inc.: Revenue Share, By Region, 2023 (%)
  39. Pfizer, Inc.: Net Sales, 2023-2033 ($ Billion)
  40. Pfizer, Inc.: Revenue Share, By Segment, 2023 (%)
  41. Pfizer, Inc.: Revenue Share, By Region, 2023 (%)
  42. Bayer AG: Net Sales, 2023-2033 ($ Billion)
  43. Bayer AG: Revenue Share, By Segment, 2023 (%)
  44. Bayer AG: Revenue Share, By Region, 2023 (%)
  45. Lily: Net Sales, 2023-2033 ($ Billion)
  46. Lily: Revenue Share, By Segment, 2023 (%)
  47. Lily: Revenue Share, By Region, 2023 (%)
  48. Ferring Pharmaceuticals Inc.: Net Sales, 2023-2033 ($ Billion)
  49. Ferring Pharmaceuticals Inc.: Revenue Share, By Segment, 2023 (%)
  50. Ferring Pharmaceuticals Inc.: Revenue Share, By Region, 2023 (%)
  51. Nucleai, Inc.: Net Sales, 2023-2033 ($ Billion)
  52. Nucleai, Inc.: Revenue Share, By Segment, 2023 (%)
  53. Nucleai, Inc.: Revenue Share, By Region, 2023 (%)
  54. Clovis Oncology,Inc.: Net Sales, 2023-2033 ($ Billion)
  55. Clovis Oncology,Inc.: Revenue Share, By Segment, 2023 (%)
  56. Clovis Oncology, Inc.: Revenue Share, By Region, 2023 (%)
  57. Eli Lilly and Company: Net Sales, 2023-2033 ($ Billion)
  58. Eli Lilly and Company: Revenue Share, By Segment, 2023 (%)
  59. Eli Lilly and Company: Revenue Share, By Region, 2023 (%)
  60. Astellas Pharma Inc.: Net Sales, 2023-2033 ($ Billion)
  61. Astellas Pharma Inc.: Revenue Share, By Segment, 2023 (%)
  62. Astellas Pharma Inc.: Revenue Share, By Region, 2023 (%)
  63. Johnson & Johnson: Net Sales, 2023-2033 ($ Billion)
  64. Johnson & Johnson: Revenue Share, By Segment, 2023 (%)
  65. Johnson & Johnson: Revenue Share, By Region, 2023 (%)
  66. Abbott Laboratories: Net Sales, 2023-2033 ($ Billion)
  67. Abbott Laboratories: Revenue Share, By Segment, 2023 (%)
  68. Abbott Laboratories: Revenue Share, By Region, 2023 (%)
  69. Gilead Sciences, Inc.: Net Sales, 2023-2033 ($ Billion)
  70. Gilead Sciences, Inc.: Revenue Share, By Segment, 2023 (%)
  71. Gilead Sciences, Inc.: Revenue Share, By Region, 2023 (%)
  72. Teva Pharmaceutical Industries Ltd: Net Sales, 2023-2033 ($ Billion)
  73. Teva Pharmaceutical Industries Ltd: Revenue Share, By Segment, 2023 (%)
  74. Teva Pharmaceutical Industries Ltd: Revenue Share, By Region, 2023 (%)
  75. Amgen, Inc.: Net Sales, 2023-2033 ($ Billion)
  76. Amgen, Inc.: Revenue Share, By Segment, 2023 (%)
  77. Amgen, Inc.: Revenue Share, By Region, 2023 (%)
  78. Others: Net Sales, 2023-2033 ($ Billion)
  79. Others: Revenue Share, By Segment, 2023 (%)
  80. Others: Revenue Share, By Region, 2023 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:115
Pages:240
Countries covered:17
Companies covered::20
Forecast CAGR:9.12%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies